Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects
Legend Biotech Corp (NASDAQ:LEGN) is one of the best biotech stocks to buy according to Wall Street analysts.
Legend Biotech Corporation (LEGN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hillhouse Capital Management Lei Zhang | 5,984,550 | $195,156,176 | 4.77% | |
| 2. | Suvretta Capital Management Aaron Cowen | 3,818,009 | $124,505,273 | +2% | 3.19% |
| 3. | Deerfield Management James E. Flynn | 2,962,338 | $96,601,842 | 1.47% | |
| 4. | Braidwell LP Alex Karnal | 1,826,155 | $59,550,915 | -29% | 1.77% |
| 5. | IvyRock Asset Management Charles Huang | 856,900 | $27,943,509 | -2% | 12.01% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 27,702,842 | $903,389,672 | 0.05% | |
| 2. | 6,094,486 | $198,741,180 | 0.83% | |
| 3. | 4,494,623 | $146,569,648 | 0% | |
| 4. | 2,547,952 | $83,088,715 | 0.12% | |
| 5. | 2,125,085 | $69,293,319 | 0.03% |
News See All
15 Best Biotech Stocks to Buy According to Wall Street Analysts
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain for the S&P 500 over the same period.
William Blair Maintains Hold Rating on Legend Biotech (LEGN) Despite Carvykti Label Safety Concerns
Legend Biotech Corporation (NASDAQ:LEGN) ranks among the most oversold biotech stocks to invest in.
9 Oversold Biotech Stocks to Invest In
Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value and healthcare.
Legend Biotech Corporation (NASDAQ:LEGN) Q3 2025 Earnings Call Transcript
Legend Biotech Corporation (NASDAQ:LEGN) Q3 2025 Earnings Call Transcript November 12, 2025Legend Biotech Corporation misses on earnings expectations.
H.C. Wainwright Remains Bullish on Legend Biotech (LEGN), Cites Solid Growth Trajectory for CARVYKTI Therapy
Discussing the company’s robust growth trajectory for its CARVYKTI therapy, he pointed toward the therapy’s rising clinical potential.
15 Stocks Set to Explode in 2026
While the market figures out whether artificial intelligence is driving the next bubble or the next industrial revolution, a quiet rotation of capital into the next wave of growth leaders outside Big ...
J.P. Morgan Maintains a Buy on Legend Biotech Corporation (LEGN)
Legend Biotech Corporation (NASDAQ:LEGN) is one of the best healthcare stocks with the highest upside. J.P.
9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
TD Cowen Reiterates a Buy Rating on Legend Biotech Corporation (LEGN)
Legend Biotech Corporation (NASDAQ:LEGN) is one of the best biotech stocks with high potential.